Presented by Agentiq: Pro sports salaries have kept pace with the S&P 500 since 2000, with a fraction of the volatility. Now you can own a piece of them.
Get $25 off your first athlete investment →

Firm commitments are getting paid this morning. The two biggest gainers are up the same amount for different reasons: a chipmaker landed long-term government financing with an equity stake attached, and a blood and plasma provider got a concrete timeline for its technology rollout.

The losers show how high the bar is running. A contract chipmaker's strong revenue beat is getting a shrug, a chip giant is slipping on a massive AI financing report, and a denim maker's softer sales outlook is outweighing its earnings beat.

What if you could invest in your favorite athlete?

Agentiq makes it real. Own fractional shares of pro athletes earnings and build a portfolio around the game you already know. The earlier you get in, the better your roster looks.

Right now, Agentiq is offering $25 off the first investment at agentiqsports.com with code LITQ25 (minimum investment is $100)

Wolfspeed (WOLF): +14%

The chipmaker is surging after securing a conditional $1.5 billion loan from the Defense Department, a 30-year financing commitment aimed at supporting domestic production. Under the proposed terms, the Pentagon would also receive warrants for up to 7.5% of the company. A loan with an equity piece attached gives Washington a direct stake in Wolfspeed's success, and the market is reading that as long-term backing for a company that needs capital to build at home.

Haemonetics (HAE): +14%

The blood and plasma provider is popping after CSL said it expects to complete the US rollout of Haemonetics' plasmapheresis platform by the end of 2027. A firm timeline from a major customer turns an adoption story into a schedule investors can actually model.

Levi Strauss (LEVI): -3%

The denim company is slipping after third-quarter revenue came in slightly short of expectations, with direct-to-consumer sales weakening in the US and Europe. Adjusted earnings beat and tariff refunds helped profitability, but the sales outlook was less optimistic, and for a brand trying to prove it can grow, the top line is what the market is watching.

Broadcom (AVGO): -2%

The chipmaker is drifting lower after a Wall Street Journal report that it's working to arrange more than $50 billion in financing tied to the custom AI chips it's developing with OpenAI. The partnership is a marquee win, but a funding need that large has investors weighing how much capital goes out the door before the payoff arrives.

Taiwan Semiconductor (TSM): -1%

The world's largest contract chipmaker reported September revenue growth of more than 50% from a year ago, pushing third-quarter sales above expectations. Shares are still down about 1% in early trading, a sign of just how high the bar sits for the world's biggest foundry.

What if you could invest in your favorite athlete?

Agentiq makes it real. Own fractional shares of pro athletes earnings and build a portfolio around the game you already know. The earlier you get in, the better your roster looks.

Right now, Agentiq is offering $25 off the first investment at agentiqsports.com with code LITQ25 (minimum investment is $100)

Webull (BULL)

Webull jumped into the top five most-discussed tickers on r/wallstreetbets and climbed to the top of StockTwits' trending list after a bipartisan House committee flagged national security concerns over the broker's China ties. The chatter is split: some traders are calling the selloff an overreaction to ties that have been public for years, while others point to ongoing insider selling as a sign the slide isn't over.

The stock fell about 20% on Wednesday, its worst day since April 2025, and is down roughly 40% over the past month, while Webull disputes the committee's findings. With earnings not due until November 12, whether the dip-buyers or the skeptics have this one right may come down to what Washington does next.

✌️That’s it for today.